- Home
- NE vs ACLX Comparison
NE vs ACLX Comparison
Compare NE & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NE
- ACLX
- Stock Information
- Founded
- NE 1985
- ACLX 2015
- Country
- NE United States
- ACLX United States
- Employees
- NE N/A
- ACLX N/A
- Industry
- NE Other Specialty Stores
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- NE Consumer Discretionary
- ACLX Health Care
- Exchange
- NE Nasdaq
- ACLX Nasdaq
- Market Cap
- NE 6.1B
- ACLX 5.3B
- IPO Year
- NE N/A
- ACLX 2022
- Fundamental
- Price
- NE $33.53
- ACLX $66.48
- Analyst Decision
- NE Buy
- ACLX Strong Buy
- Analyst Count
- NE 7
- ACLX 14
- Target Price
- NE $43.17
- ACLX $107.67
- AVG Volume (30 Days)
- NE 1.6M
- ACLX 695.1K
- Earning Date
- NE 02-20-2025
- ACLX 02-26-2025
- Dividend Yield
- NE 5.96%
- ACLX N/A
- EPS Growth
- NE 5.74
- ACLX N/A
- EPS
- NE 3.40
- ACLX N/A
- Revenue
- NE $2,645,919,000.00
- ACLX $155,818,000.00
- Revenue This Year
- NE $26.94
- ACLX $12.58
- Revenue Next Year
- NE $16.38
- ACLX N/A
- P/E Ratio
- NE $9.88
- ACLX N/A
- Revenue Growth
- NE 8.51
- ACLX 230.33
- 52 Week Low
- NE $28.40
- ACLX $47.88
- 52 Week High
- NE $52.16
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- NE 57.23
- ACLX 32.63
- Support Level
- NE $32.34
- ACLX $63.63
- Resistance Level
- NE $35.06
- ACLX $68.24
- Average True Range (ATR)
- NE 1.06
- ACLX 3.71
- MACD
- NE 0.33
- ACLX -0.69
- Stochastic Oscillator
- NE 73.20
- ACLX 16.43
About NE Noble Corporation plc A
Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and the deployment of its drilling rigs in oil and gas basins around the world.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.